EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Polypharmacy’s paradox: accelerated decline in a rare case of Lafora body disease

Tasneem Hussain iD, Krishna Gupta iD, Ashutosh Tiwari iD, Pooja S Mishra iD

Postępy Psychiatrii i Neurologii · 2026 · 35 (2) · 141-145

DOI: 10.5114/ppn.2026.161380 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Postępy Psychiatrii i Neurologii, 2026. Verfasst von Tasneem Hussain und 3 weiteren Autor:innen. Beteiligte Einrichtung: Mahatma Gandhi Memorial Medical College and M.Y. Hospital, Indore, M.P., India. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Lafora body diseaseantiepileptic drug interactioncognitive declinepolypharmacyprogressive myoclonic epilepsy

Autor:innen und Institutionen

  • Mahatma Gandhi Memorial Medical College and M.Y. Hospital, Indore, M.P., India.

ORCID-Profile: Tasneem Hussain, Krishna Gupta, Ashutosh Tiwari, Pooja S Mishra

Zitieren

APA

Hussain, T., Gupta, K., Tiwari, A., & Mishra, P. S. (2026). Polypharmacy’s paradox: accelerated decline in a rare case of Lafora body disease. Postępy Psychiatrii i Neurologii, 35(2), 141-145. https://doi.org/10.5114/ppn.2026.161380

Vancouver

Hussain T, Gupta K, Tiwari A, Mishra PS. Polypharmacy’s paradox: accelerated decline in a rare case of Lafora body disease. Postępy Psychiatrii i Neurologii. 2026;35(2):141-145. doi:10.5114/ppn.2026.161380

BibTeX
@article{Hussain2026,
  author = {Hussain, Tasneem and Gupta, Krishna and Tiwari, Ashutosh and Mishra, Pooja S},
  title = {Polypharmacy’s paradox: accelerated decline in a rare case of Lafora body disease},
  journal = {Postępy Psychiatrii i Neurologii},
  year = {2026},
  volume = {35},
  number = {2},
  pages = {141--145},
  doi = {10.5114/ppn.2026.161380}
}
Kostenlos starten →